Howard M. Katzenstein, M.D.
Director, Clinical Research and Innovative Therapy Program
The Carter Samuel Martin Children's Chair for Innovative Therapy
Associate Professor of Pediatrics
Research interests: PI of COG heptoblastoma trial; liver tumors, neuroblastoma, solid tumors and innovative therapies
Todd M. Cooper, D.O.
Director, Leukemia/Lymphoma Innovative Therapy Program
Assistant Professor of Pediatrics
Research interests: Clinical trials within COG in myeloid leukemia and development of novel therapies for children with relapsed leukemia
Tobey J. MacDonald, M.D.
Director, Pediatric Neuro-oncology Program
Associate Professor of Pediatrics
Research interests: Basic and translational research of childhood brain tumors with primary research focus on the role of platelet-derived growth factor receptor (PDGFR) signaling in medulloblastoma